跳至主要内容
临床试验/NCT01789138
NCT01789138已完成不适用

Randomized Controlled Trial of Situated Optimal Adherence Intervention Estonia (sOAI Estonia) Among Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia

University of Tartu4 个研究点 分布在 1 个国家目标入组 519 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
519
试验地点
4
主要终点
Antiretroviral Therapy (ART) Adherence (Self-reported 3-day Recall Measure)

研究概览

简要总结

The specific aim of the study is to assess antiretroviral therapy adherence and evaluate the impact of a situated treatment adherence intervention program among persons living with HIV/AIDS on antiretroviral therapy in Estonia.

详细描述

Specific antiretroviral therapy (ART) can suppress HIV replication and consequently preserve the functioning of immune system. ART is a lifelong treatment with several different concomitantly administered oral medications. According to studies, low adherence to treatment is directly related to knowledge and beliefs about ART.

Studies have shown the success of different interventions increasing adherence to ART, but additional studies need to be carried out in order to determine the most effective components of the interventions and the methods most suitable considering the local context, that could be easily incorporated into the working routine of an medical institution (clinic) with limited extra resources.

Primary locations to implement activities directed at improving treatment adherence are medical institutions, i.e. the departments of infectious diseases where persons living with HIV/AIDS receive their ART.

The aim of the study is to conduct a small-scale intervention (randomised controlled) study implementing a brief adherence counseling targeting persons receiving ART.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV infected
  • aware of the HIV-positive status for at least 3 months
  • ≥ 18 years of age
  • speak and read either Estonian or Russian
  • receive or start (on recruitment date) antiretroviral therapy

排除标准

  • under the influence of alcohol or (illicit)drugs

结局指标

主要结局

Antiretroviral Therapy (ART) Adherence (Self-reported 3-day Recall Measure)

时间窗: 12 months

次要结局

  • HIV-1 RNA Count / Viral Load (VL)(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anneli Uusküla

Professor of Epidemiology, Department of Public Health

University of Tartu

研究点 (4)

Loading locations...

相似试验